Paggiarino Dario A.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
7
Insider Sells Sum
$2.88M

Insider Activity of Paggiarino Dario A.

According to the SEC Form 4 filings, Paggiarino Dario A., being in a position of

  1. Chief Medical Officer at EyePoint Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 89224 shares for $2.17M,
    over all time since 2023-12-04, has bought 0 shares, and sold 121307 shares for $2.88M.

The largest sale of all time was on 2024-01-26 and amounted to 49325 shares of EyePoint Pharmaceuticals, Inc. for $1.27M.

Biography of Paggiarino Dario A.

No biography is available at this moment.

2024-01-26SaleEyePoint Pharmaceuticals, Inc.
EYPT
Chief Medical Officer
49,325
0.0975%
$25.66$1.27M-58.79%
2024-01-25SaleEyePoint Pharmaceuticals, Inc.
EYPT
Chief Medical Officer
600
0.0012%
$25.00$15,000-55.73%
2024-01-24SaleEyePoint Pharmaceuticals, Inc.
EYPT
Chief Medical Officer
11,251
0.0334%
$25.01$281,415-53.72%
2024-01-23SaleEyePoint Pharmaceuticals, Inc.
EYPT
Chief Medical Officer
5,135
0.0146%
$25.00$128,375-55.35%
2024-01-08SaleEyePoint Pharmaceuticals, Inc.
EYPT
Chief Medical Officer
22,913
0.0629%
$21.13$484,124-48.62%
2023-12-13SaleEyePoint Pharmaceuticals, Inc.
EYPT
Chief Medical Officer
1,458
0.004%
$20.00$29,160-42.63%
2023-12-04SaleEyePoint Pharmaceuticals, Inc.
EYPT
Chief Medical Officer
30,625
0.102%
$22.00$673,750-37.74%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.